MedPath

A study To reduce financial Burden of tuberculosis by social PROTECtion in Timor-Leste(TB-PROTECT): A Cluster Randomized Trial

Not Applicable
Completed
Conditions
Certain infectious and parasitic diseases
Registration Number
KCT0009506
Lead Sponsor
Korean National Tuberculosis Association Global Cooperation Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
320
Inclusion Criteria

A.Initiating standard 6 months treatment regimen (2RHZE/4RH) for active tuberculosis at a study facility during the study period.
B.1 months or less from the initiation of TB treatment.
C.17 years old or more

Exclusion Criteria

A.Confirmed as drug-resistant TB
B.Decided to start of switch to 2nd line drug regimen due to clinical reasons
C.Prisoners

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The proportion of TB patients who suffered from catastrophic cost due to TB
Secondary Outcome Measures
NameTimeMethod
Mean indirect cost due to TB in each group ;Mean non-medical cost in each group ;Treatment success rate in each group
© Copyright 2025. All Rights Reserved by MedPath